Wu, Xinqi <br/><br/>
VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma.  [electronic resource] 

 -  Cancer immunology research  10 2016 
 - 858-868 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>2326-6074 
<br/><br/><label>Standard No.: </label>10.1158/2326-6066.CIR-16-0084  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Neoplasm--biosynthesis<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab--administration & dosage<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Cell Adhesion--immunology<br/>Chemokine CXCL10--genetics<br/>Chemokines--blood<br/>Cytokines--blood<br/>Female<br/>Humans<br/>Intercellular Adhesion Molecule-1--metabolism<br/>Ipilimumab--administration & dosage<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Tumor Cells, Cultured<br/>Tumor Microenvironment--immunology<br/>Tumor Necrosis Factor-alpha--immunology<br/>Up-Regulation--immunology<br/>Vascular Cell Adhesion Molecule-1--metabolism